IE
IE · IE · IE-PA-EU/1/20/1457/001
Xenleta 150 mg concentrate for solution for infusion
ATC J01XX12
Last synced from HPRA (Ireland) on
Identification
ManufacturerNabriva Therapeutics Ireland Designated Activity Company
CountryIE (IE)
ATC codeJ01XX12
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/20/1457/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate and solvent for solution for infusion",
"routes": [
"Intravenous use",
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01XX",
"J01XX12"
],
"strength": null,
"pa_number": "EU/1/20/1457/001",
"substances": [
"Lefamulin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "27/07/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code J01XX12.
Access this data programmatically
Query Xenleta 150 mg concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.